<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Endoplasmic reticulum (ER) stress has been implicated in <z:chebi fb="105" ids="17234">glucose</z:chebi>-induced <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, its causal role has not been established in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>Our objective was to determine the causal role of ER stress and its link to <z:mp ids='MP_0003674'>oxidative stress</z:mp> in <z:chebi fb="105" ids="17234">glucose</z:chebi>-induced <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo> in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Healthy Wistar rats were infused i.v. with <z:chebi fb="105" ids="17234">glucose</z:chebi> for 48 h to achieve 20 mmol/l <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> with or without the co-infusion of the <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase mimetic tempol (TPO), or the chemical chaperones 4-phenylbutyrate (<z:chebi fb="3" ids="53317">PBA</z:chebi>) or tauroursodeoxycholic acid (TUDCA) </plain></SENT>
<SENT sid="4" pm="."><plain>This was followed by assessment of beta cell function and measurement of ER stress markers and <z:chebi fb="1" ids="18421">superoxide</z:chebi> in islets </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:chebi fb="105" ids="17234">Glucose</z:chebi> infusion for 48 h increased <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="1" ids="18421">superoxide</z:chebi> and ER stress markers and impaired beta cell function </plain></SENT>
<SENT sid="6" pm="."><plain>Co-infusion of TPO, which we previously found to reduce <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="1" ids="18421">superoxide</z:chebi> and prevent <z:chebi fb="105" ids="17234">glucose</z:chebi>-induced <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo>, reduced ER stress markers </plain></SENT>
<SENT sid="7" pm="."><plain>Similar to findings with TPO, co-infusion of <z:chebi fb="3" ids="53317">PBA</z:chebi>, which decreases <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="1" ids="18421">superoxide</z:chebi>, prevented <z:chebi fb="105" ids="17234">glucose</z:chebi>-induced <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo> in isolated islets </plain></SENT>
<SENT sid="8" pm="."><plain>TUDCA was also effective </plain></SENT>
<SENT sid="9" pm="."><plain>Also similar to findings with TPO, <z:chebi fb="3" ids="53317">PBA</z:chebi> prevented <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo> during hyperglycaemic clamps in vivo and after <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> (15 mmol/l) for 96 h </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS/INTERPRETATION: Here, we causally implicate ER stress in <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e>-induced <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo> in vivo </plain></SENT>
<SENT sid="11" pm="."><plain>We show that: (1) there is a positive feedback cycle between <z:mp ids='MP_0003674'>oxidative stress</z:mp> and ER stress in <z:chebi fb="105" ids="17234">glucose</z:chebi>-induced <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo>, which involves <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="1" ids="18421">superoxide</z:chebi>; and (2) this cycle can be interrupted by <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase mimetics as well as chemical chaperones, which are of potential interest to preserve beta cell function in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>